Cargando…
Growth charts for patients with Hunter syndrome()
Children with mucopolysaccharidosis II (MPS II), also known as Hunter syndrome, an X-linked disorder, suffer from a multisystem dysfunction caused by the accumulation of glycosaminoglycans. However, there has been no systemic report on the growth of patients with MPS II. The purpose of this study is...
Autores principales: | Patel, Pravin, Suzuki, Yasuyuki, Maeda, Miho, Yasuda, Eriko, Shimada, Tsutomu, Orii, Kenji E., Orii, Tadao, Tomatsu, Shunji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060980/ https://www.ncbi.nlm.nih.gov/pubmed/24955330 http://dx.doi.org/10.1016/j.ymgmr.2013.10.001 |
Ejemplares similares
-
Impact of enzyme replacement therapy and hematopoietic stem cell therapy on growth in patients with Hunter syndrome
por: Patel, Pravin, et al.
Publicado: (2014) -
Long-Term Follow-up Posthematopoietic Stem Cell Transplantation in a Japanese Patient with Type-VII Mucopolysaccharidosis
por: Orii, Kenji, et al.
Publicado: (2020) -
Assessment of Activity of Daily Life in Mucopolysaccharidosis Type II Patients with Hematopoietic Stem Cell Transplantation
por: Suzuki, Yasuyuki, et al.
Publicado: (2020) -
Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA()
por: Chinen, Yasutsugu, et al.
Publicado: (2014) -
Biomarkers in patients with mucopolysaccharidosis type II and IV
por: Fujitsuka, Honoka, et al.
Publicado: (2019)